{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:51:05Z","timestamp":1790621465407,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1007431","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000}}],"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["grant no. 1032144"],"award-info":[{"award-number":["grant no. 1032144"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI067854"],"award-info":[{"award-number":["U01 AI067854"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI081625"],"award-info":[{"award-number":["R01AI081625"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1007431","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T13:47:37Z","timestamp":1541425657000},"page":"e1007431","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6653-6655","authenticated-orcid":true,"given":"Celia C.","family":"LaBranche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-9784","authenticated-orcid":true,"given":"Matthew D.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-2345","authenticated-orcid":true,"given":"Shay","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-1937","authenticated-orcid":true,"given":"Quentin J.","family":"Sattentau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lautaro G.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin O.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-7097","authenticated-orcid":true,"given":"Leonidas","family":"Stamatatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-6319","authenticated-orcid":true,"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"issue":"6147","key":"ref1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/330487a0","article-title":"HIV infection of primate lymphocytes and conservation of the CD4 receptor","volume":"330","author":"MO McClure","year":"1987","journal-title":"Nature"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2016.02.022","article-title":"Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody","volume":"165","author":"M Bonsignori","year":"2016","journal-title":"Cell"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"e8805","DOI":"10.1371\/journal.pone.0008805","article-title":"Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals","volume":"5","author":"D Corti","year":"2010","journal-title":"PloS one"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nsmb.3291","article-title":"Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site","volume":"23","author":"HB Gristick","year":"2016","journal-title":"Nature structural & molecular biology"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth","volume":"45","author":"J Huang","year":"2016","journal-title":"Immunity"},{"issue":"7446","key":"ref6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"HX Liao","year":"2013","journal-title":"Nature"},{"issue":"6049","key":"ref7","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"JF Scheid","year":"2011","journal-title":"Science"},{"issue":"5993","key":"ref8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"X Wu","year":"2010","journal-title":"Science"},{"issue":"6049","key":"ref9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"X Wu","year":"2011","journal-title":"Science"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","article-title":"Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors","volume":"161","author":"T Zhou","year":"2015","journal-title":"Cell"},{"issue":"7601","key":"ref11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature17677","article-title":"A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges","volume":"533","author":"R Gautam","year":"2016","journal-title":"Nature"},{"issue":"7524","key":"ref12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nature13612","article-title":"Enhanced neonatal Fc receptor function improves protection against primate SHIV infection","volume":"514","author":"SY Ko","year":"2014","journal-title":"Nature"},{"issue":"21","key":"ref13","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1128\/JVI.02213-14","article-title":"Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo","volume":"88","author":"RS Rudicell","year":"2014","journal-title":"Journal of virology"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1128\/JVI.00210-15","article-title":"Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian\/Human Immunodeficiency Virus Infection","volume":"89","author":"KO Saunders","year":"2015","journal-title":"Journal of virology"},{"issue":"16","key":"ref15","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.1128\/JVI.00908-15","article-title":"Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection","volume":"89","author":"KO Saunders","year":"2015","journal-title":"Journal of virology"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1084\/jem.20132494","article-title":"Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques","volume":"211","author":"M Shingai","year":"2014","journal-title":"The Journal of experimental medicine"},{"issue":"7557","key":"ref17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"M Caskey","year":"2015","journal-title":"Nature"},{"issue":"319","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"RM Lynch","year":"2015","journal-title":"Science translational medicine"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1128\/JVI.02454-15","article-title":"Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs","volume":"90","author":"DL Bolton","year":"2015","journal-title":"Journal of virology"},{"issue":"7475","key":"ref20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"M Shingai","year":"2013","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-030409-101256","article-title":"The role of antibodies in HIV vaccines","volume":"28","author":"JR Mascola","year":"2010","journal-title":"Annual review of immunology"},{"issue":"5993","key":"ref22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"T Zhou","year":"2010","journal-title":"Science"},{"issue":"7129","key":"ref23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural definition of a conserved neutralization epitope on HIV-1 gp120","volume":"445","author":"T Zhou","year":"2007","journal-title":"Nature"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies","volume":"39","author":"T Zhou","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"e1003106","DOI":"10.1371\/journal.ppat.1003106","article-title":"Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs","volume":"9","author":"S Hoot","year":"2013","journal-title":"PLoS pathogens"},{"issue":"6133","key":"ref26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"J Jardine","year":"2013","journal-title":"Science"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.20122824","article-title":"Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies","volume":"210","author":"AT McGuire","year":"2013","journal-title":"The Journal of experimental medicine"},{"issue":"7315","key":"ref28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature09385","article-title":"Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation","volume":"467","author":"H Mouquet","year":"2010","journal-title":"Nature"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbrc.2009.09.029","article-title":"Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens","volume":"390","author":"X Xiao","year":"2009","journal-title":"Biochemical and biophysical research communications"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2014.06.022","article-title":"Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies","volume":"158","author":"F Gao","year":"2014","journal-title":"Cell"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2015.03.004","article-title":"Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection","volume":"161","author":"X Wu","year":"2015","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13783","article-title":"Structural basis for germline antibody recognition of HIV-1 immunogens","volume":"5","author":"L Scharf","year":"2016","journal-title":"eLife"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.celrep.2016.10.017","article-title":"Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors","volume":"17","author":"C Yacoob","year":"2016","journal-title":"Cell reports"},{"issue":"6060","key":"ref34","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.1213782","article-title":"Increasing the potency and breadth of an HIV antibody by using structure-based rational design","volume":"334","author":"R Diskin","year":"2011","journal-title":"Science"},{"issue":"17","key":"ref35","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1128\/JVI.00754-11","article-title":"Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01","volume":"85","author":"Y Li","year":"2011","journal-title":"Journal of virology"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.cell.2015.06.003","article-title":"Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice","volume":"161","author":"P Dosenovic","year":"2015","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1038\/ncomms10618","article-title":"Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice","volume":"7","author":"AT McGuire","year":"2016","journal-title":"Nature communications"},{"issue":"6280","key":"ref38","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1126\/science.aad9195","article-title":"HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen","volume":"351","author":"JG Jardine","year":"2016","journal-title":"Science"},{"issue":"6244","key":"ref39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.aac5894","article-title":"HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen","volume":"349","author":"JG Jardine","year":"2015","journal-title":"Science"},{"issue":"18","key":"ref40","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1016\/S0021-9258(18)86956-3","article-title":"Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells","volume":"265","author":"CK Leonard","year":"1990","journal-title":"The Journal of biological chemistry"},{"issue":"31","key":"ref41","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1073\/pnas.1006498107","article-title":"Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens","volume":"107","author":"KJ Doores","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/pr300870t","article-title":"Characterization of host-cell line specific glycosylation profiles of early transmitted\/founder HIV-1 gp120 envelope proteins","volume":"12","author":"EP Go","year":"2013","journal-title":"Journal of proteome research"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1038\/ncomms8479","article-title":"Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies","volume":"6","author":"LK Pritchard","year":"2015","journal-title":"Nature communications"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.celrep.2015.05.017","article-title":"Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers","volume":"11","author":"LK Pritchard","year":"2015","journal-title":"Cell reports"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"e23521","DOI":"10.1371\/journal.pone.0023521","article-title":"The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade","volume":"6","author":"C Bonomelli","year":"2011","journal-title":"PloS one"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2010.02.019","article-title":"Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function","volume":"401","author":"D Eggink","year":"2010","journal-title":"Virology"},{"issue":"24","key":"ref47","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1016\/S0021-9258(18)37849-9","article-title":"Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120","volume":"263","author":"H Geyer","year":"1988","journal-title":"The Journal of biological chemistry"},{"issue":"16","key":"ref48","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1128\/JVI.00628-15","article-title":"Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140","volume":"89","author":"EP Go","year":"2015","journal-title":"Journal of virology"},{"issue":"16","key":"ref49","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1128\/JVI.05053-11","article-title":"Characterization of glycosylation profiles of HIV-1 transmitted\/founder envelopes by mass spectrometry","volume":"85","author":"EP Go","year":"2011","journal-title":"Journal of virology"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1021\/pr7006957","article-title":"Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility","volume":"7","author":"EP Go","year":"2008","journal-title":"Journal of proteome research"},{"issue":"17","key":"ref51","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1128\/JVI.01190-15","article-title":"Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope","volume":"89","author":"LK Pritchard","year":"2015","journal-title":"Journal of virology"},{"issue":"13","key":"ref52","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1128\/JVI.00230-15","article-title":"Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance","volume":"89","author":"LK Pritchard","year":"2015","journal-title":"Journal of virology"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.celrep.2016.02.058","article-title":"Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein","volume":"14","author":"AJ Behrens","year":"2016","journal-title":"Cell reports"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"14954","DOI":"10.1038\/ncomms14954","article-title":"Global site-specific N-glycosylation analysis of HIV envelope glycoprotein","volume":"8","author":"L Cao","year":"2017","journal-title":"Nature communications"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.00105-10","article-title":"Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization","volume":"84","author":"JM Binley","year":"2010","journal-title":"Journal of virology"},{"issue":"21","key":"ref56","doi-asserted-by":"crossref","first-page":"13419","DOI":"10.1073\/pnas.212519299","article-title":"Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line","volume":"99","author":"PJ Reeves","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"47","key":"ref57","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"H Mouquet","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"e1007024","DOI":"10.1371\/journal.ppat.1007024","article-title":"Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation","volume":"14","author":"ET Crooks","year":"2018","journal-title":"PLoS pathogens"},{"issue":"7","key":"ref59","doi-asserted-by":"crossref","first-page":"e68863","DOI":"10.1371\/journal.pone.0068863","article-title":"The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody","volume":"8","author":"SS Balla-Jhagjhoorsingh","year":"2013","journal-title":"PloS one"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"E Falkowska","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","article-title":"Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers","volume":"40","author":"C Blattner","year":"2014","journal-title":"Immunity"},{"issue":"6287","key":"ref62","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.aae0474","article-title":"Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody","volume":"352","author":"R Kong","year":"2016","journal-title":"Science"},{"issue":"8","key":"ref63","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1128\/JVI.03608-14","article-title":"HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies","volume":"89","author":"RM Lynch","year":"2015","journal-title":"Journal of virology"},{"issue":"19","key":"ref64","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1128\/JVI.05045-11","article-title":"Analysis of a clonal lineage of HIV-1 envelope V2\/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors","volume":"85","author":"M Bonsignori","year":"2011","journal-title":"Journal of virology"},{"issue":"381","key":"ref65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7514","article-title":"Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies","volume":"9","author":"M Bonsignori","year":"2017","journal-title":"Science translational medicine"},{"issue":"336","key":"ref66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf0618","article-title":"Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages","volume":"8","author":"R Zhang","year":"2016","journal-title":"Science translational medicine"},{"issue":"8","key":"ref67","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1128\/JVI.07163-11","article-title":"Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design","volume":"86","author":"M Bonsignori","year":"2012","journal-title":"Journal of virology"},{"issue":"5187","key":"ref68","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"DR Burton","year":"1994","journal-title":"Science"},{"issue":"5628","key":"ref69","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1126\/science.1083182","article-title":"Antibody domain exchange is an immunological solution to carbohydrate cluster recognition","volume":"300","author":"DA Calarese","year":"2003","journal-title":"Science"},{"issue":"22","key":"ref70","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"MB Zwick","year":"2001","journal-title":"Journal of virology"},{"issue":"7424","key":"ref71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"J Huang","year":"2012","journal-title":"Nature"},{"issue":"7","key":"ref72","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aal2200","article-title":"Potent and broad HIV-neutralizing antibodies in memory B cells and plasma","volume":"2","author":"LD Williams","year":"2017","journal-title":"Science Immunology"},{"issue":"5950","key":"ref73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"issue":"49","key":"ref74","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"D Sok","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7365","key":"ref75","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"LM Walker","year":"2011","journal-title":"Nature"},{"issue":"5","key":"ref76","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JVI.02853-13","article-title":"Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"88","author":"A deCamp","year":"2014","journal-title":"Journal of virology"},{"issue":"16","key":"ref77","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"M Li","year":"2005","journal-title":"Journal of virology"},{"issue":"4","key":"ref78","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.celrep.2017.04.013","article-title":"Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation","volume":"19","author":"T Zhou","year":"2017","journal-title":"Cell reports"},{"issue":"18","key":"ref79","doi-asserted-by":"crossref","first-page":"9286","DOI":"10.1128\/JVI.02286-10","article-title":"epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals","volume":"85","author":"H Tang","year":"2011","journal-title":"Journal of virology"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"DC Montefiori","year":"2009","journal-title":"Methods in molecular biology"},{"issue":"18","key":"ref81","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1073\/pnas.1803457115","article-title":"Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity","volume":"115","author":"P Dosenovic","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1007646","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000}},{"DOI":"10.1371\/journal.ppat.1007431","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1007431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:29:14Z","timestamp":1662355754000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1007431"}},"subtitle":[],"editor":[{"given":"Guido","family":"Silvestri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":81,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1007431","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734367832.793552965","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]}}}